T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) Year 4, 2012
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ann Arvin, MD
Stanford University
Principal Investigator - Cornelia Dekker, MD
Stanford University
Principal Investigator - Garry Nolan, PhD
Stanford University
Principal Investigator - Mark Davis, PhD
Stanford University
Principal Investigator - Stephen Quake, PhD
Stanford University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2012
- Primary completion
- 31 Jan 2013
- Completion
- 31 Jan 2013
- Last update posted
- 22 May 2017
- Registered enrollment
- 22
- Registry id
- NCT03022435
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.